Scarica l'app Stockscreener
11.83
0.94%
0.11
Dopo l'orario di chiusura:
11.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
(FENC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fennec Pharmaceuticals (FENC): Southpoint group files 13G/A showing 0% ownership - Stock Titan
Solas Capital Management (FENC) reports 1.89M Fennec shares, a 5.4% ownership stake - Stock Titan
Results: Fennec Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views - Yahoo Finance
Fennec Pharmaceuticals Announces Q2 2026 Net Income and Revenue Growth - Kalkine Media
Fennec Pharmaceuticals (FENC) Stock Jumps As Profitability Raises A Bigger Question - webull.com
Fennec Pharmaceuticals (FENC) gains 9.6% stakeholder via Rosalind Advisors - Stock Titan
Why Fennec Pharmaceuticals Inc stock plummeted yesterday - Wealth Awesome
What's Going On With Fennec Pharmaceuticals Inc Stock Thursday? - Wealth Awesome
B. Riley Financial Reaffirms "Buy" Rating for Adherex Technologies (NASDAQ:FENC) - MarketBeat
Wedbush Boosts Adherex Technologies (NASDAQ:FENC) Price Target to $16.00 - MarketBeat
Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade) - Seeking Alpha
Why Fennec Pharmaceuticals Inc stock surged yesterday - Wealth Awesome
B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating - marketscreener.com
Fennec Pharmaceuticals Inc FRX Earnings Beat Estimates by 248.5% - Wealth Awesome
Adherex Technologies Q2 2026 Earnings Call Transcript - MarketBeat
Fennec Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $16.17, Implies 48% Upside - TradingView
Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ... - Yahoo Finance
Fennec Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Adherex Technologies Q2 Earnings Call Highlights - newsbreak.com
Fennec Pharmaceuticals at Multi-Year High After Swing to Q2 Earnings Beat - marketscreener.com
Adherex Technologies (NASDAQ:FENC) Announces Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Fennec Pharmaceuticals surges 8% as Q2 earnings and revenue beat estimates - Yahoo Finance
Fennec Pharmaceuticals Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Fennec Pharmaceuticals posts second quarter results and issues business update - tradersunion.com
Fennec Pharmaceuticals surges 8% on Q2 earnings, revenue beat By Investing.com - Investing.com Nigeria
Fennec Pharmaceuticals surges 8% on Q2 earnings, revenue beat - Investing.com
FENNEC PHARMACEUTICALS ($FENC) Releases Q2 2026 Earnings - Quiver Quantitative
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
FENC: Q2 2026 sales surged 78% year-over-year, with profitability and strong PEDMARKⓇ demand - TradingView
Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ... By GuruFocus - Investing.com Canada
Biotech Stocks At 52-Week HighsHALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE - RTTNews
Will Fennec Pharmaceuticals Inc (FRX) Beat Estimates Again in Its Next Earnings Report? - Wealth Awesome
Fennec Pharmaceuticals' Market Cap Up US$70m Following Year Of Insider Stock Buying - Moomoo
Fennec Pharmaceuticals (TSE:FRX) Sets New 12-Month HighShould You Buy? - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Above 50 Day Moving AverageTime to Sell? - MarketBeat
Responsive Playbooks and the FENC Inflection - Stock Traders Daily
Adherex Technologies (FENC) Projected to Release Quarterly Earnings on Thursday - MarketBeat
Fennec Pharmaceuticals Inc. - Menafn
Stocks in play: Fennec Pharmaceuticals Inc. - Yahoo! Finance Canada
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times
FENC Q2'26 Earnings: EPS estimate is 0.02 USD - TradingView
Fennec sets Aug. 11 call to discuss second-quarter results - Stock Titan
Fennec Pharmaceuticals (FENC) Former Director Rosty Raykov Sells 10,000 Shares - GuruFocus
Fennec Pharmaceuticals (FENC) former director sells 10,000 shares under plan - Stock Titan
Fennec Pharmaceuticals (FENC) Gains 1.67% as Shares Advance to $9.75BPI Bull Confirmed - dars.gov.et
Adherex Technologies Inc. (NASDAQ:FENC) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
FENC (NASDAQ: FENC) holder files to sell 10,000 common shares - Stock Titan
Fennec Pharmaceuticals (FENC) CMO gains 168 shares as award vests - Stock Titan
Fennec Pharmaceuticals (FENC) CEO gets 1,159-share award - Stock Titan
Fennec Pharmaceuticals (FENC) CCO receives 168 vested shares - Stock Titan
Fennec Pharmaceuticals (FENC) ex-director receives 2,778 common shares - Stock Titan
Adherex Technologies (NASDAQ:FENC) Stock Price Up 0.2%Here's Why - MarketBeat
FENC Q2'26 Earnings: revenue estimate is 16.21M USD - TradingView
Why Fennec Pharmaceuticals Inc stock is plummeting today - Wealth Awesome
Fennec Pharmaceuticals Inc (FENC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fennec Pharmaceuticals Inc (FENC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fennec Pharmaceuticals Inc (FENC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
FENC|Fennec Pharmaceuticals Inc|Price:10.205|Chg%:+0.215 - TradingKey
Fennec Pharmaceuticals Inc (FENC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fennec Pharmaceuticals Inc - TradingKey
Fennec Pharmaceuticals Inc. Revenue Breakdown – TSX:FRX - TradingView
Fennec Pharmaceuticals(FENC) Stock Options Chain | Quotes & News - Moomoo
FENC|Fennec Pharmaceuticals Inc|Price:9.990| - TradingKey
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):